Highlights
NASDAQ: CBLI       Cleveland Biolabs
Last Price Today's Change   Day's Range   Trading Volume
1.65   -0.13 (7.30%)  1.64 - 1.89  170,400

Overview

 
Avg Volume (4 weeks):215,325
4 Weeks Range:1.61 - 2.60
4 Weeks Price Volatility (%):
4.04%
52 Weeks Range:0.50 - 5.00
52 Weeks Price Volatility (%):
25.56%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Cleveland BioLabs Inc is a biopharmaceutical company. The company is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Cleveland's lead product candidate is entolimod, an immuno-stimulatory agent, which is developed as a radiation countermeasure and an immunotherapy for oncology and other indications. Entolimod is a Toll-like receptor 5 (TLR5) agonist, which is developed as a radiation countermeasure for prevention of death from Acute Radiation Syndrome (ARS), and as an oncology drug.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

5469  2756  473  149 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 GNUS 7.93+3.91 
 NIO 5.60+0.90 
 GE 7.36+0.31 
 VISL 0.425+0.086 
 F 6.19+0.29 
 SPY 312.18+4.10 
 BAC 25.99+1.15 
 AAL 11.85+0.63 
 UAL 33.65+3.74 
 SAVA 3.42+1.38 
Partners & Brokers